These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 21829007)

  • 1. Carvedilol ameliorates low-turnover bone disease in non-obese type 2 diabetes.
    Goto S; Fujii H; Kono K; Nakai K; Hamada Y; Yamato H; Shinohara M; Kitazawa R; Kitazawa S; Nishi S; Fukagawa M
    Am J Nephrol; 2011; 34(3):281-90. PubMed ID: 21829007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone formation in spontaneously diabetic Torii-newly established model of non-obese type 2 diabetes rats.
    Fujii H; Hamada Y; Fukagawa M
    Bone; 2008 Feb; 42(2):372-9. PubMed ID: 18037364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interpretation of the association between beta-blockers and hip/femur fracture.
    de Vries F; Souverein P
    Am J Nephrol; 2012; 35(1):101-2. PubMed ID: 22205435
    [No Abstract]   [Full Text] [Related]  

  • 4. Oxidative and nitrosative stress and progression of diabetic nephropathy in type 2 diabetes.
    Fujii H; Kono K; Nakai K; Goto S; Komaba H; Hamada Y; Shinohara M; Kitazawa R; Kitazawa S; Fukagawa M
    Am J Nephrol; 2010; 31(4):342-52. PubMed ID: 20224273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carvedilol improved diabetic rat cardiac function depending on antioxidant ability.
    Huang H; Shan J; Pan XH; Wang HP; Qian LB; Xia Q
    Diabetes Res Clin Pract; 2007 Jan; 75(1):7-13. PubMed ID: 16780994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of carvedilol and metoprolol on serum lipid concentration in diabetic hypertensive patients.
    Bell DS; Bakris GL; McGill JB
    Diabetes Obes Metab; 2009 Mar; 11(3):234-8. PubMed ID: 18564334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyanidin-3-O-β-D-glucopyranoside concentrated materials from mulberry fruit have a potency to protect erectile function by minimizing oxidative stress in a rat model of diabetic erectile dysfunction.
    Ha US; Koh JS; Kim HS; Woo JC; Kim SJ; Jang H; Yoon BI; Hwang SY; Kim SW
    Urol Int; 2012; 88(4):470-6. PubMed ID: 22433441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of oxidative stress in diabetic bone disorder.
    Hamada Y; Fujii H; Fukagawa M
    Bone; 2009 Jul; 45 Suppl 1():S35-8. PubMed ID: 19232402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carvedilol versus cardioselective beta-blockers for the treatment of hypertension in patients with type 2 diabetes mellitus.
    Fardoun RZ
    Pharmacotherapy; 2006 Oct; 26(10):1491-500. PubMed ID: 16999659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carvedilol ameliorates endothelial dysfunction in streptozotocin-induced diabetic rats.
    Fu GS; Huang H; Chen F; Wang HP; Qian LB; Ke XY; Xia Q
    Eur J Pharmacol; 2007 Jul; 567(3):223-30. PubMed ID: 17559835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of cilazapril, carvedilol and their combination in preventing from left ventricular remodelling after acute myocardial infarction in rats.
    Yang Y; Tang Y; Ruan Y; Li Y; Zhou Y; Gao R; Chen J; Chen Z
    J Renin Angiotensin Aldosterone Syst; 2002 Mar; 3(1):31-5. PubMed ID: 11984745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced expression of endothelial connexins 43 and 37 in hypertensive rats is rectified after 7-day carvedilol treatment.
    Yeh HI; Lee PY; Su CH; Tian TY; Ko YS; Tsai CH
    Am J Hypertens; 2006 Feb; 19(2):129-35. PubMed ID: 16448880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of carvedilol on mortality risk in heart failure patients with diabetes: results of a meta-analysis.
    Bell DS; Lukas MA; Holdbrook FK; Fowler MB
    Curr Med Res Opin; 2006 Feb; 22(2):287-96. PubMed ID: 16466600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of carvedilol versus metoprolol on endothelial function and oxidative stress in patients with type 2 diabetes mellitus.
    Bank AJ; Kelly AS; Thelen AM; Kaiser DR; Gonzalez-Campoy JM
    Am J Hypertens; 2007 Jul; 20(7):777-83. PubMed ID: 17586413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-oxidative effect of the β-blocker carvedilol on diabetic nephropathy in non-obese type 2 diabetic rats.
    Yonekura Y; Fujii H; Nakai K; Kono K; Goto S; Shinohara M; Nishi S
    Clin Exp Pharmacol Physiol; 2015 Sep; 42(9):972-978. PubMed ID: 26173411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carvedilol may alleviate late cardiac remodelling following surgical ventricular restoration.
    Yoshikawa E; Marui A; Tsukashita M; Nishina T; Wang J; Muranaka H; Ikeda T; Komeda M
    Eur J Cardiothorac Surg; 2010 Feb; 37(2):362-7. PubMed ID: 19692266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of cyclosporin A on bone mineral metabolism in experimental diabetes mellitus in the rat.
    Epstein S; Takizawa M; Stein B; Katz IA; Joffe II; Romero DF; Liang XG; Li M; Ke HZ; Jee WS
    J Bone Miner Res; 1994 Apr; 9(4):557-66. PubMed ID: 8030444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-oxidative effect of vitamin D analog on incipient vascular lesion in non-obese type 2 diabetic rats.
    Kono K; Fujii H; Nakai K; Goto S; Kitazawa R; Kitazawa S; Shinohara M; Hirata M; Fukagawa M; Nishi S
    Am J Nephrol; 2013; 37(2):167-74. PubMed ID: 23406697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of carvedilol in very elderly diabetic patients with heart failure.
    Del Sindaco D; Pulignano G; Cioffi G; Tarantini L; Di Lenarda A; De Feo S; Opasich C; Minardi G; Giovannini E; Leggio F
    J Cardiovasc Med (Hagerstown); 2007 Sep; 8(9):675-82. PubMed ID: 17700396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoregulatory effects of carvedilol on rat experimental autoimmune myocarditis.
    Liu H; Li W; Gu W; Kong Y; Yang N; Chen L
    Scand J Immunol; 2010 Jan; 71(1):38-44. PubMed ID: 20017808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.